Abstract A polymorphism in the autophagy gene Atg16l1 is associated with susceptibility to inflammatory bowel disease (IBD); however, it remains unclear how autophagy contributes to intestinal immune homeostasis. Here, we demonstrate that autophagy is essential for maintenance of balanced CD4 + T cell responses in the intestine. Selective deletion of Atg16l1 in T cells in mice resulted in spontaneous intestinal inflammation that was characterized by aberrant type 2 responses to dietary and microbiota antigens, and by a loss of Foxp3 + T reg cells. Specific ablation of Atg16l1 in Foxp3 + T reg cells in mice demonstrated that autophagy directly promotes their survival and metabolic adaptation in the intestine. Moreover, we also identify an unexpected role for autophagy in directly limiting mucosal T H 2 cell expansion. These findings provide new insights into the reciprocal control of distinct intestinal T H cell responses by autophagy, with important implications for understanding and treatment of chronic inflammatory disorders.
Introduction
Crohn's disease (CD) and ulcerative colitis (UC) are the two most common forms of inflammatory bowel disease (IBD), characterized by chronic inflammation of the gastrointestinal tract. IBD is a complex multifactorial disease that emerges on a background of many genetic and environmental factors (Maloy and Powrie, 2011) . In recent years, tremendous efforts have been undertaken to identify the genetic factors that influence susceptibility to IBD. In particular, genome-wide association studies (GWAS) and subsequent meta-analyses have identified over 150 distinct loci that influence IBD susceptibility, many of which have revealed novel pathways in disease pathogenesis (Van Limbergen et al., 2014) . Among these, a single-nucleotide polymorphism (SNP) in the essential macroautophagy (hereafter called 'autophagy') gene ATG16L1 was associated with an increased risk of CD (Hampe et al., 2007; Rioux et al., 2007) . A recent study showed that the IBD predisposing T300A mutation in the coding region of ATG16L1 led to increased degradation of ATG16L1 protein and reduced autophagy (Murthy et al., 2014) , indicating that decreased autophagy may contribute to IBD development. Polymorphisms in several other autophagy-related genes, including IRGM, LRRK2 and SMURF1, are also linked to IBD susceptibility (Van Limbergen et al., 2014) , suggesting that changes in the autophagy pathway alter intestinal homeostasis and predispose to chronic intestinal inflammation.
Autophagy is a highly conserved cellular process that targets cytoplasmic components for lysosomal degradation and maintains homeostasis by recycling damaged organelles and large cytoplasmic protein aggregates. Autophagy becomes particularly important during metabolic or infectious stress (Mizushima, 2007) . Atg16l1 forms an essential autophagy complex with Atg5 and Atg12 that facilitates elongation of the initial isolation membrane that results in engulfment of the cargo and formation of the autophagosome. Subsequent fusion with the lysosome facilitates degradation and allows nutrient recycling (Mizushima et al., 2003) . To identify the mechanisms through which autophagy may regulate intestinal tissue homeostasis, it is essential to understand the functional consequences of alterations in autophagy on both immune and tissue cells present in the gut. To date, several studies have examined the role of autophagy and Atg16l1 in intestinal epithelial cells and myeloid cells for intestinal homeostasis. In these studies, Atg16l1 was shown to play a role in Paneth cell physiology, as well as in bacterial handling and regulation of inflammatory IL-1b secretion by myeloid cells (Cadwell et al., 2008; Kuballa et al., 2008; Saitoh et al., 2008; Plantinga et al., 2011) . However, the role of Atg16l1 in intestinal adaptive immune responses has not yet been addressed. CD4 + T cells constitute the largest population of intestinal lymphocytes and are central mediators of host protective and tolerogenic responses in the gut (Shale et al., 2013) . In particular, thymusderived and peripherally induced Foxp3 + CD4 + regulatory T cells (tT reg and pT reg cells, respectively)
are indispensable in promoting tolerance toward commensal and dietary antigens and for the prevention of aberrant effector T cell responses, including T H 1, T H 2 and T H 17 cell responses (Izcue et al., 2009 ). An imbalance between effector and regulatory CD4 + T cells can promote chronic intestinal inflammation and accumulation of effector CD4 + T cells in the inflamed mucosa is a cardinal feature of IBD (Abraham and Cho, 2009; Maloy and Powrie, 2011; Shale et al., 2013) .
eLife digest The gut presents a puzzle to our immune system. Immune cells must rapidly respond to antigens produced by harmful bacteria, but food and the beneficial bacteria that inhabit the gut also produce antigens that our immune system must tolerate. Inappropriate immune responses in the gut can lead to inflammatory bowel disease, a debilitating disease with no current cure. We do not fully understand why these harmful inflammatory responses arise, but we know that genetic factors are important. Mutations in genes that affect a process known as autophagy -a pathway that breaks down and recycles unwanted material inside cells -make inflammatory bowel disease more likely to develop, but exactly how they do so remains unclear. T helper cells are crucial controllers of intestinal immune responses and changes in their numbers and behaviour occur during inflammatory bowel disease. Kabat et al. explored how the autophagy pathway affects these key immune cells in mice. Blocking autophagy in T cells altered the balance of different types of T helper cells in the gut. A crucial population of regulatory T cells, which keep inflammatory responses in check, was lost. At the same time, another population of T cells expanded: the T helper 2 (T H 2) cells that are responsible for driving allergies. As a result, the mice developed intestinal inflammation and produced antibodies against gut bacteria and food.
Overall, Kabat et al. ' s results show that autophagy defects can alter the balance of different types of T cells in the gut, leading to inflammation in the intestine. These observations contribute to our understanding of how genetic changes may influence susceptibility to inflammatory bowel disease. They also suggest that drugs that activate autophagy could help to treat diseases associated with changes in regulatory T cells or T H 2 cells, including inflammatory bowel disease and allergies. It will now be important to test this and to confirm whether similar changes in T cells are present in humans that have mutations in autophagy genes.
Therefore, it is important to define factors that regulate aberrant CD4 + T cell responses in the gastrointestinal tract. Previous studies utilizing mice with T-cell-specific deletion of essential autophagy genes (Atg3, Atg5, Atg7, Beclin1) pointed to a key role of autophagy in T cell homeostasis, as these mice exhibited decreased frequencies and numbers of CD4 + and CD8 + T cells and defects in T cell proliferation in vitro (Pua et al., 2009; Stephenson et al., 2009; Jia and He, 2011; Kovacs et al., 2012) . In addition, recent studies highlighted the importance of autophagy in the development of memory CD8 + T cells (Puleston et al., 2014; Xu et al., 2014; Schlie et al., 2015) . However, the exact requirements for autophagy during different stages of T cell activation and differentiation remain poorly understood . Given that the gastrointestinal tract is a site of continuous immune activation by external antigens and is therefore a challenging environment for the adaptive immune system, we hypothesized that a selective defect in autophagy may affect intestinal T cell homeostasis. We investigated the role of Atg16l1 in intestinal CD4 + T cells by generating mice that selectively lack Atg16l1 in T cells. Here, we show that T-cell-specific deletion of Atg16l1 results in chronic intestinal inflammation accompanied by increased humoral responses toward commensal and dietary antigens. We further demonstrate that Atg16l1-deficiency has opposing effects on intestinal CD4 + T cells subsets; markedly enhancing T H 2 responses whilst decreasing T reg cell numbers. Through selective ablation of Atg16l1 in T reg cells, we established the importance of cell-intrinsic autophagy for intestinal T reg cell homeostasis. Furthermore, through complementary in vivo approaches we show that autophagy controls T H 2 responses through two distinct mechanisms; through a cell-intrinsic pathway and by promoting extrinsic regulation by T reg cells.
Results

Selective deletion of Atg16l1 in T cells results in spontaneous intestinal pathology
To investigate the role of autophagy in intestinal T cell homoeostasis, mice carrying loxP-flanked alleles of the essential autophagy gene Atg16l1 (Atg16l1 fl/fl ) were crossed with CD4-Cre mice, generating Atg16l1 fl/fl ::CD4-Cre mice (hereafter denoted as Atg16l1 DCD4 ) in which
Atg16l1 is selectively ablated in T cells from the double-positive stage of thymic development. To verify functional deletion of Atg16l1 autophagy levels were analyzed by autophagosome formation and LC3 lipidation. CD4 + T cells isolated from control Atg16l1 fl/fl mice exhibited increased LC3 + autophagosome formation after activation, as measured by intracellular LC3 accumulation in the presence of a lysosomal inhibitor ( Figure 1A ). In contrast, there was no increase in intracellular LC3 accumulation in CD4 + T cells from Atg16l1 DCD4 mice ( Figure 1A ). To verify this finding using another method, we assessed LC3 lipidation by Western blot analysis (Klionsky et al., 2012) . Activated control Atg16l1 fl/fl CD4 + T cells exhibited increased lipidated LC3 II levels in the presence of chloroquine, indicative of autophagy-mediated turnover of LC3 II after T cell activation ( Figure 1B) . However, LC3 II levels in CD4 + T cells from Atg16l1 DCD4 mice were barely affected by activation ( Figure 1B) , confirming a block in autophagy. Young Atg16l1 DCD4 mice appeared normal, initially gained weight in a manner comparable to Atg16l1 fl/fl littermates and exhibited normal intestinal morphology ( Figure 1C ,F-H). However, from around 5 months of age, Atg16l1 DCD4 mice stopped gaining weight ( Figure 1C ), developed splenomegaly and lymphadenopathy ( Figure 1D ,E) and chronic intestinal pathology that progressed with age ( Figure 1F-I ). Atg16l1 DCD4 mice exhibited significant inflammation of both the small intestine (SI) and colon, characterized by increased SI length, marked lengthening of crypts, shortening of villi and epithelial hyperplasia ( Figure 1F-I) . Thus, T-cell-specific Atg16l1 deletion resulted in spontaneous intestinal inflammation and systemic immune activation.
Atg16l1 deficiency has opposing effects on intestinal T reg and T H 2 cells
To characterize the effects of Atg16l1 on intestinal and systemic T cell homeostasis independently from any confounding effects of ongoing tissue inflammation, we analyzed young (8-12 weeks old) Atg16l1 DCD4 mice before the onset of inflammatory pathology or systemic symptoms. Whilst thymic T cell production was unperturbed in Atg16l1 DCD4 mice (Figure 2 -figure supplement 1A,B), frequencies of CD4 + and CD8 + T cells in peripheral lymphoid organs were significantly decreased Atg16l1 DCD4 and Atg16l1 fl/fl mice after overnight activation with or without a-CD3 (5 mg/ml) and a-CD28 (1 mg/ml). (B) Western blot analysis of LC3 lipidation in naïve splenic CD4 + T cells isolated from Atg16l1 DCD4 mice and Atg16l1 fl/fl mice after 3hr activation with a-CD3 (5 mg/ml) and a-CD28 (1 mg/ ml) with or without chloroquine (CQ, inhibitor of lysosomal degradation, 50 mM). or combined from two (G) or three (I) independent experiments, with at least 3 mice per group. Data shown as mean ± s.e.m (A,C). Each dot represents an individual mouse and horizontal bars denote means (E,G). In (I) each dot represents an individual crypt measurement and horizontal bars denote , although, due to decreased colonic CD4 + T cell numbers, total T H 1 and T H 17 numbers were significantly decreased ( Figure 2C ). Conversely, both frequencies and total numbers of T H 2 (IL-13 + )
cells were significantly increased in cLP of young Atg16l1 DCD4 mice ( Figure 2B-D) . These IL-13-producing cells were bona fide T H 2 cells, as they co-expressed the lineage-specifying transcription factor Gata3 ( Figure 2D ,E). Interestingly, T H 2 cell accumulation was primarily observed in the intestinal mucosa of Atg16l1 DCD4 mice, as T H 2 cell frequencies were only marginally increased in the mLN and remained unchanged in the spleen ( Figure 2E ). However, the functional consequences of T H 2 expansion extended beyond the intestine, as Atg16l1 DCD4 mice had increased frequencies of eosinophils in both the spleen and mLN and elevated serum levels of mast cell protease 1 (MCPT-1), a marker of intestinal mast cell activation ( We also found that cLP T reg cells from young Atg16l1 DCD4 mice showed higher expression of CD103 and CTLA-4, but showed decreased expression of the activation markers CD25, CD69, and the terminal differentiation marker KLRG-1 (Figure 2-figure supplement 4F ). In addition, intestinal T reg cells from young Atg16l1 DCD4 mice had significantly increased expression of Ki67 and higher levels of phosphorylated S6, suggesting that the majority were in cell cycle (Figure 2 -figure supplement 4G-I). Taken together, these results identify a crucial role for autophagy in the maintenance and functional regulation of intestinal T reg cells.
Overall, these results demonstrate that selective ablation of Atg16l1 in T cells led to a decrease in Foxp3 + T reg cells and selective expansion of T H 2 cells that preceded the onset of overt pathology. In addition, these perturbations in T H cell subsets were largely limited to the mucosal environment. Figure 3A) . Furthermore, levels of serum IgA and IgG 1 in young Atg16l1 DCD4 mice were also significantly elevated relative to Atg16l1 fl/fl littermates ( Figure 3 -figure supplement 1A) and again increased as the Atg16l1 DCD4 mice aged ( Figure 3B ). In contrast, levels of isotypes not associated with T H 2 help were identical in aged Atg16l1 DCD4 mice and Atg16l1 fl/fl littermates ( Figure 3B ). (Berin and Sampson, 2013) . We hypothesized that the aberrant humoral responses in Atg16l1 DCD4 mice might be directed against luminal antigens. Soy is the main protein source in chow, and we detected high levels of anti-soy IgG 1 and IgA in sera from aged Atg16l1 DCD4 mice, whereas these responses were undetectable in control Atg16l1 fl/fl littermates ( Figure 3D ). By contrast, we only detected marginal levels of soy-specific IgG 2b or IgG 2c in aged Atg16l1 DCD4 sera ( Figure 3D ). Importantly, elevated anti-soy IgG 1 and IgA antibodies were already present in sera from young Atg16l1 DCD4 mice, before the onset of intestinal inflammation (Figure 3-figure supplement 1C). Despite the very high levels of total serum IgE in aged Atg16l1 DCD4 mice, we did not detect elevated levels of anti-soy IgE (data not shown).
The absence of soy-specific IgE could be due to the inhibiting effects of persistent exposure to highdose antigens on IgE responses (Sudowe et al., 1997; Riedl et al., 2005) . Therefore, to test whether an IgE response was mounted during transient exposure to low-dose dietary antigens, we fed young Atg16l1 DCD4 and Atg16l1 fl/fl mice with ovalbumin (OVA), either alone or in combination with the mucosal adjuvant cholera toxin (CT). As expected, anti-OVA IgE responses were undetectable in control Atg16l1 fl/fl mice fed OVA alone and were only marginally increased by co-administration of CT ( Figure 3E ). In contrast, Atg16l1 DCD4 mice exhibited significantly elevated levels of anti-OVA IgE after being fed OVA alone and developed >10-fold higher levels of OVA-specific IgE after feeding of OVA with CT ( Figure 3E ). Together, these results indicate that Atg16l1 DCD4 mice displayed aberrant T H 2-associated antibody responses towards otherwise innocuous dietary protein antigens. Besides food antigens, the intestinal lumen harbors vast quantities of commensal-derived antigens. Thus, we measured antibodies directed against the flagellin antigen CBir1, produced by commensal bacteria belonging to Clostridia cluster XIVa, as antibodies against flagellin are readily detected in sera of IBD patients (Lodes et al., 2004) . We detected significantly higher levels of CBir1-specific IgG 1 and IgA in the serum of aged Atg16l1 DCD4 mice compared to control Atg16l1 fl/fl littermates, whereas anti-CBir1 IgG 2b and IgG 2c levels were comparable ( Figure 3F ). Furthermore, CBir1-specific IgG 1 and IgA were already detectable in young Atg16l1 DCD4 mice (data not shown). In Naïve Atg16l1 DCD4 or Atg16l1 fl/fl CD4 + T cells were cultured with (E) 1 mg/ml or (F) 5 mg/ml anti-CD3 plus anti-CD28 (1 mg/ml) for 48 hr in T reg or T H 2 polarizing conditions, then maintained in polarizing conditions for a further 5 days before FACS analysis of cell survival. Figure 4E,F) . In contrast, there was a 50-75% decrease in survival of Atg16l1-deficient T reg cells when compared to Atg16l1-sufficient T reg cells activated under the same conditions ( Figure 4E ,F). To establish whether autophagy-deficient T reg and T H 2 cells exhibited similarly distinct survival profiles in vivo CD4 + T cells isolated from cLP of Atg16l1 DCD4 or Atg16l1 fl/fl littermates were stained with a viability dye and Annexin V. We observed that an increased proportion of Atg16l1-deficient intestinal T reg cells were dead or dying compared to WT T reg cells ( Figure 4G ). In contrast, Atg16l1-deficiency had no negative effect on the viability of intestinal T H 2 cells, which was comparable to WT controls ( Figure 4G ). Together, these results indicate that Atg16l1-deficiency does not impair the differentiation or stability of T reg cells and does not promote differentiation towards the T H 2 lineage. However, autophagy differentially impacts on the survival of mucosal T reg and T H 2 cells.
Autophagy regulates intestinal T H 2 responses in a cell-intrinsic manner
As pT reg cells are required to control T H 2 responses at mucosal sites (Mucida et al., 2005; Curotto de Lafaille et al., 2008; Josefowicz et al., 2012) , we examined whether the enhanced T H 2 phenotype in Atg16l1 DCD4 mice could be corrected by reconstitution of the intestinal Foxp3 + T reg compartment. We restored the pTreg population in young Atg16l1 DCD4 mice at the age of 10-12 weeks, before the onset of intestinal pathology, through adoptive transfer of congenic WT naïve CD45.1 + CD4 + T cells. Recipients were sacrificed 3 months later, when control Atg16l1 DCD4 littermates had developed intestinal inflammation. We detected CD45.1 + donor CD4 + T cells in all adoptively transferred Atg16l1 DCD4 mice, but the level of reconstitution varied by the organ examined. In reconstituted Atg16l1 DCD4 mice, donor WT CD4 + T cells accounted for 37 ± 5% of total CD4 + T cells in spleen and 18 ± 2% in mLN, whereas in the cLP they represented 56 ± 4% ( Figure 5A ). cells were of WT donor origin (67 ± 5% in spleen, 59 ± 4% in mLN and 80 ± 5% in cLP) ( Figure 5B ). Thus, adoptive transfer of WT-naïve CD4 + T cells resulted in efficient reconstitution of Foxp3 + pT reg cells in Atg16l1 DCD4 mice; the total frequencies and numbers of T reg cells within the cLP of transferred mice were comparable with control Atg16l1 fl/fl mice ( Figure 5-figure supplement 1B ). As such, we could utilize this system to determine whether excessive T H 2 cell accumulation in Atg16l1 DCD4 mice was due to impaired mucosal pT reg cells or to a cell-intrinsic effect of Atg16l1-deficiency in T H 2 cells. When we analyzed the frequencies of T H 2 cells in the cLP of reconstituted Atg16l1 DCD4 mice, we observed significantly higher frequencies of Gata3 + IL-13 + T H 2 cells among Atg16l1-deficient Figure 5F -H).
Autophagy is essential for T reg cell homeostasis and control of effector T cell responses in the gut
Given that Atg16l1-deficiency significantly reduced the number of intestinal T reg cells in Atg16l1 DCD4 mice, we hypothesized that T reg cells may be particularly reliant on autophagy compared to other subsets of CD4 + T cells. Indeed, in WT mice we found that levels of autophagy were significantly higher in Foxp3 + T reg cells compared to Foxp3 -CD4 + T cells, both constitutively and after TCR activation ( Figure 6A ,B). Together with our observations of impaired survival of Atg16l1-deficient To definitively assess the cell-intrinsic requirement for autophagy in Foxp3 + T reg cells we crossed T cells in the spleen, mLN and cLP of aged Atg16l1 DFoxp3 mice ( Figure 7G ). Analyses of humoral responses in aged Atg16l1 DFoxp3 mice revealed significantly elevated levels of circulating IgE and IgA, however IgG 1 levels were not increased ( Figure 7H and 
Differential survival of autophagy-deficient T reg cells and T H 2 cells is associated with an altered metabolic profile
Finally, we investigated mechanisms that might underlie the striking survival defect of Atg16l1-deficient intestinal T reg cells. Analyses of key regulators of apoptosis revealed that Atg16l1-deficient T reg cells isolated from spleen and cLP had comparable expression of pro-apoptotic (Bim, Bax) and antiapoptotic (Bcl2) genes as those isolated from control mice (Figure 8-figure supplement 1B) . As recent evidence suggests that tissue-resident T reg cell populations may exhibit specialized metabolic adaptations (Burzyn et al., 2013) , we compared the expression of metabolic genes by WT and Atg16l1-deficient T reg cells. Analyses of genes involved in glycolysis, fatty acid synthesis (FAS) and fatty acid oxidation (FAO), revealed that Atg16l1-deficient T reg cells had higher expression of glycolytic genes, including Glut1, Slc16a3, Tpi1, Ldh-a, Aldo-a, Gpi1 and Pgk1, than control T reg cells ( Figure 8C ). Strikingly, this augmented glycolytic signature was much more pronounced in Atg16l1-deficient T reg cells isolated from cLP versus those from the spleen ( Figure 8C ). Conversely, expression of many key genes involved in FAS/FAO, including Acc1, Acc2, Srebf1, Srebf2, Fdft1, Fabp1, Fabp4 and Fabp5 was markedly decreased in Atg16l1-deficient T reg cells ( Figure 8D) . Again, these differences were most pronounced in the intestine; WT cLP T reg cells showed increased FAS/FAO gene expression compared to their spleen counterparts, whereas Atg16l1-deficient cLP T reg cells were not able to up-regulate the expression of FAS/FAO genes ( Figure 8D) . Thus, Atg16l1-deficiency profoundly influenced the expression of metabolic genes in intestinal T reg cells, with an altered balance of glycolytic and FAS/FAO gene expression. Further evidence of increased reliance on lipid metabolism by colonic T reg cells was provided by our observation that T reg cells isolated from the cLP showed markedly increased lipid uptake in comparison to mLN or spleen T reg cells (Figure 8-figure supplement 2A,B) . A similar pattern was observed when we assayed expression of CD36, a fatty acid translocase that enhances FA uptake: colonic T reg cells showed increased expression of CD36 compared to splenic and mLN Treg cells (Figure 8-figure supplement 2C,D) . Interestingly, we found that Atg16l1-deficient T reg cells showed comparable levels of lipid uptake and CD36 expression as their autophagy-sufficient counterparts (Figure 8-figure supplement 2A-D) , suggesting that autophagy does not affect lipid uptake per se but rather affects lipid metabolism.
Together, these results demonstrate that cell-intrinsic autophagy is indispensable for Foxp3 + T reg cell maintenance and function in peripheral tissues, particularly to suppress inflammatory responses within the gastrointestinal tract. Decreased survival of Atg16l1-deficient T reg cells was associated with an altered metabolic profile, suggesting that autophagy plays an integral role in facilitating the metabolic adaptions required for long-term T reg cell survival in the intestine. We next explored whether autophagy had a general effect on T cell metabolic profile and whether this might explain the differential effects on T H 2 cells and T reg cells. Evidence that this might be the case came from our observation that Atg16l1-deficient naïve CD4 + T cells exhibited increased cell size compared with naïve CD4 + T cells isolated from Atg16l1 fl/fl littermates ( Figure 8-figure   supplement 3A) . We therefore measured oxygen consumption rate (OCR), which is an indicator of oxidative phosphorylation (OXPHOS), and extracellular acidification rate (ECAR), an indirect indicator of aerobic glycolysis. We found that Atg16l1-deficient naïve CD4 + T cells exhibited significantly increased OCR and ECAR, metabolic changes that are typically observed in activated CD4 + T cells and are associated with increased aerobic glycolysis (Figure 8-figure supplement 3B ).
As T H 2 cells have previously been reported to display an increased glycolytic rate compared to other T H subsets (Michalek et al., 2011; Yang et al., 2013) , we hypothesized that they may be more resistant to the increased glycolysis that is induced in the absence of autophagy. As it was not possible to sort T H 2 cells from the cLP, we performed this analysis on in vitro cultures of T H 2 and T reg cells. We found that T H 2 cells were larger than T reg cells, expressed higher levels of c-Myc, a critical regulator of metabolic reprograming in activated T cells, and had markedly higher ECAR, all indicative of enhanced aerobic glycolysis (Figure 8-figure supplement 3C-E) . Furthermore, while Atg16l1-deficient T reg cells showed higher expression of c-Myc, significantly increased levels of ECAR and OCR, and were larger than their control Atg16l1-sufficient counterparts, we observed constitutively high and comparable levels of glycolysis in Atg16l1-deficient and Atg16l1-sufficient T H 2 cells (Figure 8 -figure supplement 3C-E). These patterns were recapitulated when expression of key metabolic genes were analyzed; T H 2 cells showed high expression of a panel of glycolytic genes irrespective of their autophagy Atg16l1 genotype, whereas T reg cell expression of glycolytic genes was generally lower, unless the T reg cells were autophagy-deficient (Figure 8 -figure supplement 3F). Taken together, these results suggest that the enhanced glycolytic metabolism constitutively employed by T H 2 cells makes them more resistant to the metabolic changes that occur in the absence of autophagy.
Discussion
The unique challenges of the intestine necessitate complex mechanisms of tolerance and immune regulation to maintain homeostasis (Izcue et al., 2009) . As altered mucosal CD4 + T cell responses are implicated in intestinal diseases of increasing prevalence, including food allergies and IBD (Maloy and Powrie, 2011; Berin and Sampson, 2013) , it is important to understand the factors that control effector and regulatory T cell homeostasis in the gut. Here, we identify Atg16l1 and autophagy as a new critical pathway regulating intestinal T reg and T H 2 responses. Recent studies addressing the role of autophagy in distinct leukocyte populations have highlighted T cells as being very sensitive to perturbations in the autophagy pathway (Ma et al., 2013) . Our data extend these findings by showing that autophagy is particularly important for the survival of CD4 + T cells within the gut environment, as Atg16l1 deletion in T cells led to a severe reduction of CD4 + T cell numbers in the intestinal LP. This deficit was confirmed in mixed bone marrow chimeras, where Atg16l1-deficient CD4 + T cells failed to reconstitute the intestinal LP compartment, and by the rapid outgrowth of adoptively transferred WT CD4 + T cells in the colonic LP of Atg16l1 DCD4 recipients. However, despite the reduction in intestinal CD4 + T cells, Atg16l1 DCD4 mice spontaneously developed progressive, chronic intestinal inflammation. To confirm their increased predisposition to develop intestinal pathology, we used an experimental model of IBD triggered by infection with Helicobacter hepaticus and concomitant treatment with anti-IL-10R mAbs (SongZhao and Maloy, 2014) . This model induces severe typholocolitis that is T cell dependent and displays several features of human IBD pathology and does not require any specific genetic manipulation or chemical barrier disruption. We found increased intestinal pathology in Atg16l1 DCD4 mice, confirming that Atg16l1-deficient T cells could mediate potent inflammatory responses in the gut. Thus, selective autophagy deficiency within T cells decreases the competitiveness of these cells and simultaneously predisposes to intestinal inflammation.
We found that Atg16l1 DCD4 mice exhibited a drastic reduction in Foxp3 + T reg populations in the cLP and SI LP, together with marked changes in intestinal T reg phenotype, including increased cell cycling and aberrant production of T H effector cytokines. The role of autophagy in Foxp3 + T reg cells
is not well defined. T cell-specific ablation of Vps34, which encodes a class III phosphatidylinositol 3-kinase that promotes autophagy, resulted in decreased frequencies of T reg cells in the thymus, spleen and lymph nodes (Parekh et al., 2013) . However, as Vps34 also has autophagy-independent functions (Backer, 2008) , it was unclear as to what extent these changes were due to impaired autophagy. Furthermore, we did not find any deficit in thymic T reg cell development in Atg16l1-deficient T cells. However, we observed that T reg cells isolated from the mLN and colonic LP had increased levels of autophagy compared to effector T cells, suggesting that autophagy is particularly important for the maintenance of T reg cells in the periphery. Indeed, we demonstrated that cellintrinsic autophagy is indispensible for the maintenance and function of Foxp3 + T reg cells in the gastrointestinal tract, as selective deletion of Atg16l1 in the Foxp3 + T reg compartment in Atg16l1 DFoxp3 mice led to a loss of intestinal Foxp3 + T reg cells and to severe inflammation of the small intestine and colon. In this context, it is pertinent that rapamycin, which induces autophagy through its inhibitory activity on mTOR, has been shown to promote expansion of T reg cells in vitro and in vivo (Pollizzi and Powell, 2015) . Similarly, several small-molecule inducers of autophagy were shown to selectively promote the development of T reg cells in vitro (Shaw et al., 2013) . Taken together with our findings, these observations suggest that boosting autophagy may represent a rational therapeutic approach to enhance T reg responses in the intestine. How does autophagy intrinsically regulate T reg cell homeostasis? Our data indicate that autophagy is not required for the differentiation of Foxp3 + T reg cells in vitro or in vivo for thymic generation of T reg cells in vivo. However, we found that Atg16l1-deficient T reg cells showed significantly decreased survival compared to WT T reg cells both in vitro and in vivo. As recent evidence indicates that T reg cells utilize a distinct metabolic program that favors lipid oxidation for energy provision (MacIver et al., 2013) , one potential explanation is that autophagy regulates T reg cell metabolism and thereby their survival. Indeed, we found that Atg16l1-deficient T reg cells expressed a distinct metabolic profile to their WT counterparts, exhibiting increased expression of genes involved in glycolysis and reduced expression of genes involved in FAS/FAO. Fatty acid metabolism is emerging as a potent regulator of T cell responses and preferential utilization of FAO has been linked to T reg cell induction (Lochner et al., 2015) . Although a recent report indicated that de novo FAS was not required for Foxp3 + T reg cell differentiation (Berod et al., 2014) , optimal in vivo T reg cell function was associated with intrinsic lipid synthesis (Zeng et al., 2013) . Furthermore, autophagy has been implicated in the regulation of fatty acid metabolism (Singh et al., 2009; Lizaso et al., 2013; Kaur and Debnath, 2015) and recent studies found that autophagy plays a key role in the generation of CD8 + memory T cells (Puleston et al., 2014; Xu et al., 2014) , which are heavily dependent on FAO for survival (Pearce et al., 2009; O'Sullivan et al., 2014) . Thus, autophagy could play a similar survival role in T reg cells, by facilitating the degradation of intracellular lipid stores to release FAs that fuel FAO. Additionally, as degradation of intracellular lipids by autophagy is important to avoid lipotoxicity (Galluzzi et al., 2014) , defective autophagy could lead to a toxic build up of intracellular lipids in intestinal T reg cells. The imbalance between glycolysis and FAS/FAO observed in autophagy-deficient T reg cells could indicate that these cells have stalled in the activated/effector state and are unable to make the metabolic adaptations necessary for long-term survival. This is supported by our data showing that a higher proportion of autophagy-deficient T reg cells appear to be in cell cycle, but they have reduced expression of terminal differentiation markers. Consistent with our findings, a recent study reported that autophagy deficiency in T reg cells resulted in increased mTORC1 activation and glycolysis, leading to phenotypic instability, including expression of pro-inflammatory cytokines (Wei et al., 2016) . However, the molecular mechanism behind decreased survival of autophagy-deficient T reg cells was not elucidated (Wei et al., 2016) . It is striking that autophagy deficiency had a more detrimental effect on intestinal T reg cells than on those found in secondary lymphoid organs. Recent evidence suggests that tissue-resident T reg cells undergo tissue-specific adaptations, and metabolic changes are emerging as an important facet of such reprogramming (Burzyn et al., 2013; Liston and Gray, 2014) . Taken together, our results suggest that autophagy endows intestinal T reg cells with the metabolic flexibility required to survive in the gut tissue, where essential growth factors may be in short supply (Pearce et al., 2013) .
Paralleling decreased T reg responses in Atg16l1 DCD4 mice, we observed a selective expansion of T H 2 cells in the intestinal LP that was already present in young mice and preceded the onset of overt pathology. Our subsequent analyses indicated that autophagy limits mucosal T H 2 cells through both cell-intrinsic and cell-extrinsic (T reg -mediated) regulation. One possibility is that Atg16l1-deficient T H 2 cells may be somewhat resistant to T reg suppression. However, when we reconstituted pT reg cells in Atg16l1 DCD4 mice we observed a negative correlation between the numbers of intestinal T reg cells and T H 2 cells (data not shown), suggesting that autophagy-deficient T H 2 cells are partially controlled by T reg cells. Our data strongly suggest that the intrinsic survival advantage of Atg16l-deficient T H 2 cells is primarily responsible for their outgrowth in the intestine. Indeed, we observed increased survival of Atg16l1-deficient T H 2 cells in vitro, suggesting that autophagy might directly inhibit T H 2 cell expansion. This concept is consistent with a previous study that reported enhanced survival of T H 2 cells in vitro when autophagy was inhibited and that autophagy mediated death of T H 2 cells during growth-factor withdrawal (Li et al., 2006) . However, we provide evidence for an additional mechanism that could explain the preferential expansion of Atg16l1-deficient T H 2 cells in the intestine, related to the unique ability of T H 2 cells to cope with prolonged high levels of glycolysis. Our data contribute to accumulating evidence that a shift toward glycolysis is a general phenomenon observed when the autophagy pathway is perturbed in T cells. We observed characteristic signs of increased glycolysis in Atg16l1-deficient naïve CD4 + T cells and T reg cells, such as increases in cell size, c-Myc levels and expression of glycolytic genes, as well as elevated ECAR. Others have reported a similar glycolytic shift in autophagy-deficient CD8 + memory T cells (Puleston et al., 2014) and T reg cells (Wei et al., 2016) . Interestingly, T H 2 cells have previously been shown to display an increased glycolytic rate compared to other T H subsets (Michalek et al., 2011; Yang et al., 2013) . We confirmed the high levels of constitutive glycolysis in T H 2 cells and showed that these were comparable in Atg16l1-deficient and control T H 2 cells. Moreover, Gata3 activation was previously linked to induction of glycolysis after TCR activation in T cells, through induction of c-Myc, a critical regulator of metabolic reprograming (Wang et al., 2011; Wang et al., 2013; Wan, 2014) .
We therefore propose that in T H 2 cells Gata3 orchestrates metabolic adaptations that enable these cells to cope with prolonged high levels of glycolysis, thus making them resistant to metabolic changes enforced by autophagy deficiency. Overall, our results indicate that autophagy is a key pathway through which T H 2 responses are restrained in vivo. A lack of this restraint leads to a gradual loss of tolerance to intestinal antigens, as the excessive T H 2 responses in Atg16l1 DCD4 mice led to production of IgG 1 and IgA antibodies toward commensal microbiota and dietary antigens that increased with age. Furthermore, Atg16l1 DCD4 mice developed very high levels of circulating IgE, and mounted de novo IgE antibody responses toward introduced dietary antigen. As polymorphisms in autophagy genes are linked to IBD susceptibility, our results point towards a novel mechanism that links impaired autophagy to intestinal inflammation through dysregulation of mucosal T cell responses. Previous studies focused on the role of ATG16L1 and autophagy in myeloid cells and the intestinal epithelium. They suggested that impaired autophagy could result in reduced intestinal barrier integrity due to impaired Paneth cell function within the intestinal epithelial layer and elevated cytokine responses by macrophages and dendritic cells (Cadwell et al., 2008; Saitoh et al., 2008; Lassen et al., 2014) . Our data add a further layer to the control of intestinal homeostasis by autophagy, by showing that autophagy impairment alters the local T cell compartment and promotes T cell driven intestinal pathology. We present compelling evidence that autophagy deficiency in T reg cells leads to a deficit in intestinal T reg cells and the development of severe intestinal pathology. Although the contribution of the T H 2 axis to IBD remains unclear (Strober et al., 2002; Shale et al., 2013) , polymorphisms in IL-4, IL-5 and IL-13 have been implicated by GWAS in both CD and UC (Van Limbergen et al., 2014) and elevated levels of antibodies recognizing food and commensal antigens have been detected in IBD patients (Lodes et al., 2004; Cai et al., 2014) . Moreover, as defective T reg and increased T H 2 responses at the mucosa are observed in food allergies and asthma, our findings might also have implications for these conditions. Indeed, epidemiological studies show an overlap between IBD and T H 2 driven diseases, such as atopic dermatitis and asthma (Lees et al., 2011) . Furthermore, polymorphisms in the essential autophagy gene Atg5 have recently been implicated in asthma susceptibility Poon et al., 2012) . Autophagy is an attractive therapeutic target and several autophagy modulating compounds are already in clinical trials for the treatment of various disorders (Jiang and Mizushima, 2014) . Furthermore, natural dietary-derived compounds, including retinoid acid (Isakson et al., 2010) and vitamin D (Yuk et al., 2009) , have been shown to enhance autophagy. Taken together with our results, these findings raise the possibility that activation of autophagy through dietary or pharmacological modulation might have beneficial effects in disorders with a signature of decreased T reg and elevated T H 2 responses, including intestinal inflammation and various hypersensitivities.
Materials and methods
Mice
Atg16l1
fl/fl mice were generated and provided by the H. Virgin laboratory (Washington University, Saint Louis, MO), as described ) were bred and maintained under specific pathogen-free conditions. Unless stated otherwise, mice were analyzed at 8-12 weeks (young mice) or > 5 months of age (aged mice). In the gene expression analysis Atg16l1 DFoxp3 mice and Foxp3 Cre mice were cohoused and age-and sex-matched. In all other experiments mice used were age-and sex-matched littermates that were kept co-housed throughout the experiments.
T cell-mediated colitis
Experimental T cell-mediated colitis was induced by infection with Helicobacter hepaticus and concomitant IL-10R blockade as described (Song-Zhao and Maloy, 2014) . Briefly, mice were infected with H.hepaticus (10 8 CFU per mouse) by oral gavage on three consecutive days and anti-IL-10R mAb (1B1.2) was administrated via i.p. injection (1 mg per mouse) on the first and seventh day of the infection. Mice were sacrificed 2 weeks after colitis induction.
Histological assessment of intestinal inflammation
Mice were euthanized at indicated time points whereupon tissue sections were fixed in buffered 10% formalin and paraffin-embedded. Sections were then cut and stained with hematoxylin and eosin. Histological analysis of intestinal inflammation was performed as described (Song-Zhao and Maloy, 2014) . Briefly, inflammation was graded semi-quantitatively on a scale from 0 to 3, for four criteria; (a) epithelial hyperplasia and goblet cell depletion, (b) lamina propria leukocyte infiltration, (c) area of tissue affected, and (d) markers of severe inflammation, including crypt abscesses, submucosal inflammation, and ulceration. Scores for individual criteria were totaled for an overall inflammation score between 0 and 12.
Isolation of cells and flow cytometry analysis
Cell suspensions were prepared from the thymus, spleen, mLN, bone marrow and intestinal lamina propria as previously described (Uhlig et al., 2006) . The following antibodies from eBioscience (Hatfield, UK) were used: anti-CD16/32 (93), anti-CD4 (GK1.5), anti-CD8a (53.6.7), anti-TCRb (H57-597),
2), anti-IL-17A (eBio17B7), anti-IL-13 (eBio13A).
The following antibodies were from BioLegend (San Diego, CA): anti-CD138 (281-2), anti-CD161 (PK136), anti-F4/80 (BMB), anti-CD11b (M1/70). The following antibodies were from BD Biosciences (San Jose, CA): anti-B220 (RA3 6B2), anti-GL7 (GL7), anti-CD95 (Jo2), anti-CD3 (145-2C11), anti-CD19 (1D3), anti-Ly6C (AL-21), anti-Ly6G (1A8), anti-IgM (R6-60.2), anti-IgG1 (A85-1). Anti-c-Myc antibody was from Cell Signaling Technology (D84C12, Danvers, MA). Anti-Neuropilin1 polyclonal antibody was from R&D Systems (FAB566A, Minneapolis, MN). Fixable Viability Dye from eBioscience was used to stain dead cells. Annexin V staining was performed using eBioscience kit (88-08006) according to manufacture instructions. For intracellular cytokine staining cells were stimulated for 3h with PMA (100ng/ml) and Ionomycin (1 mg/ml) in the presence of Brefeldin A (10 mg/ml).
Autophagosome formation detection by flow cytometry was performed using FlowCellect Autophagy LC3 Antibody-based Assay Kit (FCCH100171, Merk-Millipore, Billerica, MA) according to the manufacturer's instructions and following cell surface markers staining. The Autophagy LC3 Antibody-based Assay Kit involves a permeabilization step to wash out cytosolic LC3-I, allowing for antibody-based detection of membrane bound LC3-II. For autophagy detection in WT T reg cells B6 Foxp3 hCD2 were used, as this allowed the detection of Foxp3 + T reg cells on the basis of surface expression of hCD2 marker. All data were acquired using a Cyan ADP (Beckman Coulter, High Wycombe, UK) and analyzed using FlowJo software (Tree Star, Ashland, OR).
CD4 + T cell purification
Bulk CD4 + T cells were purified from the spleen and mLN by negative selection as previously described (Coccia et al., 2012 
Immunization with ovalbumin (OVA)
For induction of OVA-specific IgE antibodies two treatment regimes were utilized. For OVA only immunization mice were fed three times by oral gavage with ovalbumin grade VII (5 mg per mouse, Sigma-Aldrich, St Louis, MO) with 21-day intervals between feeds. For adjuvanted immunization, mice were initially fed with OVA (5 mg per mouse) plus cholera toxin (10 mg per mouse, Biologial Compbell), after which they were fed twice with OVA only (5mg per mouse), with 21-day intervals between feeds.
Infection with Trichuris muris and detection of T. muris-specific IgG 1
Mice were orally infected with~200 Trichuris muris eggs. Serum was collected on day 34-post infection and assayed by ELISA for parasite-specific IgG 1 . Ninety-six-well plates were coated with 5 mg/ml T. muris excretory/secretory antigen and incubated with serial two-fold diluted serum. Bound IgG 1 was detected using biotinylated anti-murine IgG 1 (AbD Serotec, Kidlington, UK).
Lipid uptake measurement
Atg16l1 fl/fl and Atg16l1 DCD4 mice were injected i.p. with 50 mg of fluorescent 16-carbon fatty acid analog BODIPY C-16 (Molecular Probes) reconstituted in DMSO. Mice were culled 1 hr later and tissue collected for analysis by flow cytometry.
Metabolic analysis using XF 96 extracellular flux analyzer
The real-time extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were measured using a XF 96 extracellular flux analyzer (Seahorse Bioscience, Billerica, MA). Briefly, naïve (CD62L + CD44 -) CD4 + T cells, or in vitro polarized T H 2 and T reg cells, were washed twice in assay medium (RPMI 1640 without sodium bicarbonate, 20 mM glucose, 1% FCS, 2mM pyruvate) and seeded at 3-4 x 10 5 cells per well in assay medium in a 96-well XF plate coated with poly-L-lysine (Sigma). T cells were rested for 1 hr at 37˚C without CO 2 before analysis.
Polarization and stimulation of CD4 + T cell subsets Naïve CD4 + T cells were cultured (3x10 5 cells/well) in 96-well plates coated with anti-CD3 mAb (5 mg/ml) and soluble anti-CD28 mAb (1 mg/ml) and kept in presence of IL-2 (100 U/ml). For T H 0 conditions anti-IL-4 (10 mg/ml) and anti-IFN-g (10 mg/ml) mAb were added. Cultures were supplemented with IL-12 (10 ng/ml) and anti-IL-4 mAb (10 mg/ml) for T H 1 polarization; with IL-4 (20 ng/ml), anti-IFN-g (20 mg/ml) and anti-IL-12 (10 mg/ml) for T H 2 polarization; and with TGF-b1 (5 ng/ml), anti-IFNg, anti-IL-4 mAb and anti-IL-12 (all 10 mg/ml) for induced T reg polarization. Sorted T reg cells were activated for 48h with anti-CD3 mAb (5 mg/ml) and soluble anti-CD28 mAb (1 mg/ml) plus IL-2 (100 U/ ml) and then cultured with IL-4 (10 ng/ml), IL-13 (10 ng/ml) and IL-2 (100 U/ml) for 5 days. All cytokines were from R&D Systems. Anti-CD3 (145-2C11), anti-CD28 (37.51), anti-IFN-g (XMG1.2), anti-IL-12 (C17.8) and anti-IL-4 (11B11) mAb were from eBioscience. Cells were cultured in RPMI-1640 Medium, 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml of Penicillin/Streptomycin, and 0.05 mM 2-mercaptoethanol.
Measurement of serum antibodies and cytokines
All immunoglobulin isotypes except for IgE were measured by enzyme-linked immunosorbent assay (ELISA) using the SBA Clonotyping System (Southern Biotech, Birmingham, AL). IgE concentration was determined using an anti-mouse IgE ELISA (BioLegend), according to manufacturer's instructions. For the detection of soy-specific, CBir-specific and Helicobacter-specific antibodies ELISA was performed with plates coated with purified soy antigen (5 mg/ml), CBir peptide (10 mg/ml) and soluble Helicobacter antigen (sHel antigen, 10 mg/ml) respectively. sHel antigen was prepared as previously described (Kullberg et al., 1998) . For the detection of OVA-specific IgE, a sandwich ELISA was performed with biotinylated-OVA used for detection. MCPT-1 concentrations were measured by ELISA (eBioscience).
Immunofluorescence microscopy
Colonic and small intestine tissue samples were formalin-fixed, paraffin-embedded and sectioned as per histological analysis. Sections were deparaffinized, rehydrated, and subjected to sodium citratebased antigen retrieval, then stained with mouse pAb anti-b-catenin (610153, BD Bioscience), rabbit pAb anti-CD3 (ab5690, Abcam, Cambridge, UK) and secondary goat antibodies conjugated to AlexaFluor488 or 555 (Life Technologies, Carlsbad, CA). Slides were mounted with DAPI-containing Vectashield (Vector Laboratories, Burlingame, CA). Images were acquired with an Olympus Fluoview FV1000 confocal microscope and Olympus Fluoview Software (Olympus, Tokyo, Japan).
Western blotting analysis CD4 + T cells purified by negative selection were lysed in RIPA buffer containing protease inhibitor cocktail (Roche, Basel, Switzerland). Protein levels were normalized by Biorad DC protein assay (BioRad Laboratories, Hercules, CA), resolved by SDS-PAGE and, following transfer onto nitrocellulose membranes, were blotted with anti-LC3 antibody (L7543; Sigma-Aldrich) and anti-tubulin antibody (sc5286, Santa Cruz Biotechnology, Dallas, TX), and secondary HRP conjugated anti-rabbit antibody (7074S, Cell Signaling Technology).
Fluidigm gene expression analysis CD4 + T cells and T reg cells were sorted for each population based on surface marker and YFP expression from spleen and cLP of Atg16l1 DFoxp3 and Foxp3 Cre mice. Two hundred cells/population were sorted in triplicates from a total of four (spleen) or six (cLP) mice per group. Alternatively, 250 cells from in vitro polarized populations of T H 2 and T reg cells were sorted from triplicate culture wells. RNA was reverse transcribed and cDNA was pre-amplified using the CellsDirect OneStep q-RT kit (Invitrogen). The selected autophagy, apoptotic and metabolic genes were amplified and analyzed for expression using a dynamic 48x48 array (Biomark Fluidigm) as previously described (Tehranchi et al., 2010) . Data were analyzed using the 2 -DCt method, and the results were normalized to actin or HPRTprt expression.
Statistical analysis
For weight curves and antibody titers, p-values were determined by two-way ANOVA with Bonferroni post-tests. For the metabolic analysis using XF 96 extracellular flux analyzer, p-values were determined using unpaired Student's t-test. For all other experiments, p-values were determined by nonparametric Mann-Whitney test. Differences were considered statistically significant when p<0.05 (*<p0.05, **p<0.01, ***p<0.001). Data are shown as mean ± s.e.m. Statistics were calculated using GraphPad Prism 6 software. For in vivo experiments, sample size was determined by power analysis using power of trial software, which calculates a power value based on X 2 test statistics. Calculated required sample sizes were applied whenever possible. No mouse was excluded from the analysis. With the exception of histological assessment of intestinal inflammation, experimenters were not 'blinded' to allocation of animals to experimental groups.
